Mediclinic’s share price surged more than 11% on Friday, its best day in 15 months, after SA’s most valuable hospital operator reported a bounce-back in revenue for its local unit amid a promising return of non-elective surgeries.

The group, valued at R46.2bn on the JSE, operates in Switzerland, the Middle East and SA. Like other hospital operators it was hit by the pandemic, which resulted in additional staff and equipment costs, while nonurgent medical procedures were put off...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now